$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000088559019000037 Filed on November 04, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$2.224B	$2.209B	$2.136B
YoY Change	4.86%	3.42%	-3.74%
Cost Of Revenue	$635.0M	$584.0M	$582.0M
YoY Change	5.48%	0.34%	-10.46%
Gross Profit	$1.589B	$1.625B	$1.554B
YoY Change	4.61%	4.57%	-0.96%
Gross Profit Margin	71.45%	73.56%	72.75%
Selling, General & Admin	$668.0M	$648.0M	$614.0M
YoY Change	6.71%	5.54%	-1.44%
% of Gross Profit	42.04%	39.88%	39.51%
Research & Development	$114.0M	$123.0M	$107.0M
YoY Change	-5.0%	14.95%	32.1%
% of Gross Profit	7.17%	7.57%	6.89%
Depreciation & Amortization	$492.0M	$520.0M	$703.0M
YoY Change	-9.89%	-26.03%	0.72%
% of Gross Profit	30.96%	32.0%	45.24%
Operating Expenses	$1.217B	$771.0M	$721.0M
YoY Change	-2.48%	6.93%	2.41%
Operating Profit	-$1.076B	$329.0M	$117.0M
YoY Change	-4404.0%	181.2%	207.89%
Interest Expense	-$392.0M	-$395.0M	-$417.0M
YoY Change	-3.69%	-5.28%	-4.58%
% of Operating Profit		-120.06%	-356.41%
Other Income/Expense, Net		-$10.00M	$15.00M
YoY Change		-166.67%	-95.38%
Pretax Income	-$1.470B	-$66.00M	-$300.0M
YoY Change	245.07%	-78.0%	-25.0%
Income Tax	$47.00M	-$18.00M	$51.00M
% Of Pretax Income
Net Earnings	-$1.516B	-$48.00M	-$351.0M
YoY Change	340.7%	-86.32%	-127.0%
Net Earnings / Revenue	-68.17%	-2.17%	-16.43%
Basic Earnings Per Share		-$0.14	-$1.00
Diluted Earnings Per Share	-$4.298M	-$0.14	-$1.00
COMMON SHARES
Basic Shares Outstanding	352.4M shares	352.4M shares	351.5M shares
Diluted Shares Outstanding		352.4M shares	351.5M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.243B	$825.0M	$973.0M
YoY Change	349.79%	-15.21%	0.93%
Cash & Equivalents	$3.243B	$825.0M	$973.0M
Short-Term Investments
Other Short-Term Assets	$780.0M	$633.0M	$757.0M
YoY Change	12.88%	-16.38%	-54.94%
Inventory	$1.107B	$1.100B	$971.0M
Prepaid Expenses
Receivables	$1.839B	$1.747B	$2.041B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.969B	$4.305B	$4.742B
YoY Change	65.5%	-9.22%	-20.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.466B	$1.390B	$1.341B
YoY Change	8.35%	3.65%	-4.08%
Goodwill	$13.13B	$13.05B	$13.29B
YoY Change	-0.12%	-1.79%	-14.66%
Intangibles	$10.20B	$10.65B	$12.66B
YoY Change	-15.0%	-15.84%	-21.02%
Long-Term Investments
YoY Change
Other Assets	$411.0M	$402.0M	$108.0M
YoY Change	277.06%	272.22%	-28.95%
Total Long-Term Assets	$26.89B	$27.36B	$29.04B
YoY Change	-4.9%	-5.76%	-14.68%
TOTAL ASSETS
Total Short-Term Assets	$6.969B	$4.305B	$4.742B
Total Long-Term Assets	$26.89B	$27.36B	$29.04B
Total Assets	$33.86B	$31.67B	$33.78B
YoY Change	4.22%	-6.25%	-15.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$503.0M	$437.0M	$440.0M
YoY Change	22.38%	-0.68%	8.11%
Accrued Expenses	$4.511B	$3.198B	$3.424B
YoY Change	41.1%	-6.6%	0.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$1.234B	$100.0M	$298.0M
YoY Change	441.23%	-66.44%	-67.78%
Total Short-Term Liabilities	$6.248B	$3.735B	$4.162B
YoY Change	62.88%	-10.26%	-11.97%
LONG-TERM LIABILITIES
Long-Term Debt	$24.66B	$23.47B	$24.43B
YoY Change	2.43%	-3.96%	-6.8%
Other Long-Term Liabilities	$851.0M	$760.0M	$532.0M
YoY Change	46.47%	42.86%	421.57%
Total Long-Term Liabilities	$25.51B	$24.23B	$24.97B
YoY Change	3.46%	-2.96%	-5.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.248B	$3.735B	$4.162B
Total Long-Term Liabilities	$25.51B	$24.23B	$24.97B
Total Liabilities	$32.73B	$29.11B	$30.54B
YoY Change	10.28%	-4.69%	-11.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.452B	-$5.936B	-$5.320B
YoY Change	31.57%	11.58%	64.25%
Common Stock	$10.60B	$10.57B	$10.53B
YoY Change	0.64%	0.46%	0.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.063B	$2.482B	$3.153B
YoY Change
Total Liabilities & Shareholders Equity	$33.86B	$31.67B	$33.78B
YoY Change	4.22%	-6.25%	-15.5%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$1.516B	-$48.00M	-$351.0M
YoY Change	340.7%	-86.32%	-127.0%
Depreciation, Depletion And Amortization	$492.0M	$520.0M	$703.0M
YoY Change	-9.89%	-26.03%	0.72%
Cash From Operating Activities	$234.0M	$515.0M	$522.0M
YoY Change	-26.65%	-1.34%	6.53%
INVESTING ACTIVITIES
Capital Expenditures	-$85.00M	-$83.00M	-$27.00M
YoY Change	32.81%	207.41%	-43.75%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$10.00M	$32.00M
YoY Change	-100.0%	-68.75%	-96.51%
Cash From Investing Activities	-$85.00M	-$73.00M	$5.000M
YoY Change	37.1%	-1560.0%	-99.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.255B	-474.0M	-386.0M
YoY Change	-549.2%	22.8%	-73.01%
NET CHANGE
Cash From Operating Activities	$234.0M	$515.0M	$522.0M
Cash From Investing Activities	-85.00M	-73.00M	5.000M
Cash From Financing Activities	2.255B	-474.0M	-386.0M
Net Change In Cash	$234.0M	$515.0M	$522.0M
YoY Change	-26.65%	-1.34%	6.53%
FREE CASH FLOW
Cash From Operating Activities	$234.0M	$515.0M	$522.0M
Capital Expenditures	-$85.00M	-$83.00M	-$27.00M
Free Cash Flow	$319.0M	$598.0M	$549.0M
YoY Change	-16.71%	8.93%	2.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2018Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2019Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	349871102	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	352387430	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	349871102	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	352387430	shares
CY2019Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	302000000	USD
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
	us-gaap	Sublease Income SubleaseIncome	0	USD
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-14956
	dei	Entity Registrant Name EntityRegistrantName	Bausch Health Companies Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0448205
	dei	City Area Code CityAreaCode	514
	dei	Local Phone Number LocalPhoneNumber	744-6792
	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 St. Elzéar Blvd. West
	dei	Entity Address City Or Town EntityAddressCityOrTown	Laval
	dei	Entity Address State Or Province EntityAddressStateOrProvince	QC
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	H7L 4A8
	dei	Trading Symbol TradingSymbol	BHC
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	109000000	USD
CY2019Q3	us-gaap	Assets Assets	31667000000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	352431217	shares
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	825000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	721000000	USD
CY2019Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	2000000	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2000000	USD
CY2019Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	1747000000	USD
CY2018Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1865000000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	1100000000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	934000000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	631000000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	689000000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	4305000000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	4211000000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1390000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1353000000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10650000000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12001000000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	13052000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	13142000000	USD
CY2019Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1868000000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1676000000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	402000000	USD
CY2018Q4	us-gaap	Assets Assets	32492000000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	437000000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	411000000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3198000000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3197000000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	100000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	228000000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3735000000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3836000000	USD
CY2019Q3	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	267000000	USD
CY2018Q4	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	298000000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23466000000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	10168000000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	10121000000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24077000000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	879000000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	885000000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	760000000	USD
CY2019Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	123000000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	581000000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	29107000000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	29677000000	USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6377000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6259000000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	648000000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	406000000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	413000000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5936000000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5664000000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2156000000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2137000000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	2482000000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	2733000000	USD
CY2019Q3	us-gaap	Minority Interest MinorityInterest	78000000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	82000000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2560000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2815000000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31667000000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32492000000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2209000000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2136000000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	614000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1886000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1847000000	USD
CY2018Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	107000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	357000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	293000000	USD
CY2019Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	475000000	USD
CY2018Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	658000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1452000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2142000000	USD
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2213000000	USD
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	33000000	USD
CY2018Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	89000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	49000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	434000000	USD
CY2019Q3	us-gaap	Restructuring Charges RestructuringCharges	4000000	USD
CY2018Q3	us-gaap	Restructuring Charges RestructuringCharges	3000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	28000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	16000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	873000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2409000000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-3000000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	19000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-2000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	23000000	USD
CY2019Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-10000000	USD
CY2018Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	15000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-15000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3000000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	1880000000	USD
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	2019000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	5504000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	8668000000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	329000000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	117000000	USD
CY2019Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	406000000	USD
CY2018Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	420000000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1221000000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1271000000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-40000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-75000000	USD
CY2019Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	9000000	USD
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	18000000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-66000000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-300000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-367000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3728000000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18000000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-101000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74000000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-48000000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-351000000	USD
	us-gaap	Profit Loss ProfitLoss	-266000000	USD
	us-gaap	Profit Loss ProfitLoss	-3802000000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-49000000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-350000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-272000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3804000000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-10.83
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	352400000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	351500000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	351900000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	351100000	shares
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-48000000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-351000000	USD
	us-gaap	Profit Loss ProfitLoss	-266000000	USD
	us-gaap	Profit Loss ProfitLoss	-3802000000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-97000000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-159000000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2018Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1000000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1000000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	2000000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-97000000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-161000000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-145000000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-339000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-287000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3963000000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1000000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4000000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-144000000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-335000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-291000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3961000000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2688000000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26000000	USD
CY2019Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1000000	USD
CY2019Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-48000000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-97000000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2560000000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3558000000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22000000	USD
CY2018Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1000000	USD
CY2018Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3000000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-351000000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12000000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3237000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2815000000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77000000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	40000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000000	USD
	us-gaap	Profit Loss ProfitLoss	-266000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21000000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2560000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5944000000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1209000000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	65000000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9000000	USD
	us-gaap	Profit Loss ProfitLoss	-3802000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-161000000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3237000000	USD
	us-gaap	Profit Loss ProfitLoss	-266000000	USD
	us-gaap	Profit Loss ProfitLoss	-3802000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1583000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2273000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	49000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	62000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	49000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	434000000	USD
	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	2000000	USD
	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-23000000	USD
	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	46000000	USD
	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	48000000	USD
	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-233000000	USD
	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-2000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	10000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-26000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-12000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	30000000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	4000000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	222000000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2213000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	77000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	65000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-8000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	16000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-40000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-75000000	USD
	bhc	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	1000000	USD
	bhc	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	2000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-27000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	19000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-110000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-56000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	205000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	53000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-33000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	107000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1267000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1182000000	USD
	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	180000000	USD
	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-5000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000	USD
	bhc	Payment Of Deferred Consideration PaymentOfDeferredConsideration	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	76000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	192000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95000000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8000000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	44000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	32000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-334000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-134000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3238000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7471000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3956000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8200000000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	12000000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	12000000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1000000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	40000000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	27000000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	26000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	26000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	62000000	USD
	bhc	Payment Of Deferred Consideration PaymentOfDeferredConsideration	18000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-812000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-851000000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17000000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-21000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	104000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	176000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	723000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	797000000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	827000000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	973000000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	825000000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	973000000	USD
CY2019Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	2000000	USD
CY2018Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	827000000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	973000000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Bausch Health Companies Inc. (the “Company”) is a pharmaceutical and medical device company that develops, manufactures, and markets, primarily in the therapeutic areas of eye-health, gastroenterology ("GI") and dermatology, a broad range of: (i) branded pharmaceuticals, (ii) generic and branded generic pharmaceuticals, (iii) over-the-counter (“OTC”) products and (iv) medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in approximately </span><span style="font-family:inherit;font-size:10pt;"><span>100</span></span><span style="font-family:inherit;font-size:10pt;"> countries.</span></div>
CY2019Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In preparing the unaudited Consolidated Financial Statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited Consolidated Financial Statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</span></div>
	us-gaap	Payments For Proceeds From Hedge Investing Activities PaymentsForProceedsFromHedgeInvestingActivities	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	302000000	USD
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2384000000	USD
	us-gaap	Valuation Allowances And Reserves Reserves Of Businesses Acquired ValuationAllowancesAndReservesReservesOfBusinessesAcquired	16000000	USD
	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	3860000000	USD
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	4104000000	USD
CY2019Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2156000000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2546000000	USD
	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	4468000000	USD
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	4514000000	USD
CY2018Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2500000000	USD
	bhc	Highly Liquid Investments Maturity Period HighlyLiquidInvestmentsMaturityPeriod	P3M
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	387000000	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	339000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-23000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	28000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	28000000	USD
CY2019Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	313000000	USD
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	336000000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	46000000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	54000000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	267000000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	282000000	USD
CY2019Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	317000000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	275000000	USD
CY2019Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	171000000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	95000000	USD
CY2019Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	612000000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	564000000	USD
CY2019Q3	us-gaap	Inventory Gross InventoryGross	1100000000	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	934000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25545000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16610000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8935000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25485000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15218000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10267000000	USD
CY2019Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27260000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16610000000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10650000000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27219000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15218000000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12001000000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	38000000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	341000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	444000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1623000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1374000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1224000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1080000000	USD
CY2019Q3	bhc	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	952000000	USD
CY2019Q3	bhc	Finite Lived Intangible Assets Amortization Expense Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseThereafter	2238000000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8935000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	15593000000	USD
CY2018	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	2000000	USD
CY2018	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	127000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	13142000000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	3000000	USD
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	18000000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	75000000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	13052000000	USD
CY2019Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	3711000000	USD
CY2019Q3	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	987000000	USD
CY2018Q4	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	998000000	USD
CY2019Q3	bhc	Accrued Product Return Current AccruedProductReturnCurrent	679000000	USD
CY2018Q4	bhc	Accrued Product Return Current AccruedProductReturnCurrent	813000000	USD
CY2019Q3	us-gaap	Interest Payable Current InterestPayableCurrent	388000000	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	273000000	USD
CY2019Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	291000000	USD
CY2018Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	301000000	USD
CY2019Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	150000000	USD
CY2018Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	167000000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	703000000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	645000000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3198000000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3197000000	USD
CY2019Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	23841000000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	23566000000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	24632000000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	24305000000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	100000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	228000000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23466000000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24077000000	USD
CY2018Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	74000000	USD
CY2018Q2	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	4000000	USD
CY2018Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	25000000	USD
	bhc	Debt Instrument Redemption Price Percentage Changein Control DebtInstrumentRedemptionPricePercentageChangeinControl	1.01
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8000000	USD
CY2019Q3	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0639
CY2018Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0623
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	100000000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	203000000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1553000000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3788000000	USD
CY2019Q3	bhc	Long Term Debt Maturities Repayments Of Principal In Year Six LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix	2303000000	USD
CY2019Q3	bhc	Long Term Debt Maturities Repayments Of Principal Thereafter LongTermDebtMaturitiesRepaymentsOfPrincipalThereafter	15894000000	USD
CY2019Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	23841000000	USD
CY2019Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	275000000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	23566000000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	263000000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49000000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	235000000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	284000000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	15000000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	47000000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	3000000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	12000000	USD
CY2019Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1000000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	56000000	USD
	bhc	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	28000000	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
	bhc	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	28000000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	282000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	16000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	63000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	49000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	39000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34000000	USD
CY2019Q3	bhc	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	28000000	USD
CY2019Q3	bhc	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	146000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	375000000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	91000000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	284000000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49000000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	235000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	78000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	60000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	44000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	39000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	32000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	166000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	419000000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	77000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65000000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	77000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65000000	USD
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	119000000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M15D
CY2019Q3	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2019Q3	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	114000000	USD
CY2018Q3	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	98000000	USD
	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	329000000	USD
	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	265000000	USD
CY2019Q3	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	9000000	USD
CY2018Q3	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	9000000	USD
	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	28000000	USD
	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	28000000	USD
CY2019Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	123000000	USD
CY2018Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	107000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	357000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	293000000	USD
CY2019Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000000	USD
CY2018Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-26000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	10000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-26000000	USD
CY2019Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2018Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	8000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1000000	USD
CY2019Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-9000000	USD
CY2018Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	40000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-12000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	30000000	USD
CY2019Q3	bhc	Other Miscellaneous Nonoperating Income Expense OtherMiscellaneousNonoperatingIncomeExpense	-2000000	USD
CY2018Q3	bhc	Other Miscellaneous Nonoperating Income Expense OtherMiscellaneousNonoperatingIncomeExpense	1000000	USD
	bhc	Other Miscellaneous Nonoperating Income Expense OtherMiscellaneousNonoperatingIncomeExpense	-5000000	USD
	bhc	Other Miscellaneous Nonoperating Income Expense OtherMiscellaneousNonoperatingIncomeExpense	0	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-101000000	USD
	bhc	Effective Income Tax Rate Reconciliation Discrete Items Amount EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount	-46000000	USD
	bhc	Effective Income Tax Rate Reconciliation Deductible Royalty Expense Benefit Amount EffectiveIncomeTaxRateReconciliationDeductibleRoyaltyExpenseBenefitAmount	-32000000	USD
	bhc	Effective Income Tax Rate Reconciliation Benefit Filing Tax Returns Amount EffectiveIncomeTaxRateReconciliationBenefitFilingTaxReturnsAmount	13000000	USD
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-55000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74000000	USD
	bhc	Effective Income Tax Rate Reconciliation Discrete Items Amount EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount	203000000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Restructuring Charges IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges	255000000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	57000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-129000000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3126000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2913000000	USD
CY2019Q3	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	622000000	USD
CY2018Q4	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	654000000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	48000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	42000000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	316000000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-49000000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-350000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-272000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3804000000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	352400000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	351500000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	351900000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	351100000	shares
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-10.83
CY2019Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	20000000	USD
CY2019Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	475000000	USD
CY2018Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	658000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1452000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2142000000	USD
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2213000000	USD
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	33000000	USD
CY2018Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	89000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	49000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	434000000	USD
CY2019Q3	us-gaap	Restructuring Charges RestructuringCharges	4000000	USD
CY2018Q3	us-gaap	Restructuring Charges RestructuringCharges	3000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	28000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	16000000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-3000000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	19000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-2000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	23000000	USD
CY2019Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-10000000	USD
CY2018Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	15000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-15000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3000000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	329000000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	117000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	873000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2409000000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	USD
CY2019Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	406000000	USD
CY2018Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	420000000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1221000000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1271000000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-40000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-75000000	USD
CY2019Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	9000000	USD
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	18000000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-66000000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-300000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-367000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3728000000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2209000000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2136000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6377000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6259000000	USD
	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2209000000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2136000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6377000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6259000000	USD

Files In Submission

Name	View Source	Status
0000885590-19-000037-index-headers.html	Edgar Link	pending
0000885590-19-000037-index.html	Edgar Link	pending
0000885590-19-000037.txt	Edgar Link	pending
0000885590-19-000037-xbrl.zip	Edgar Link	pending
bauschhealthcompaniesi.htm	Edgar Link	pending
bauschhealthcompaniesi_htm.xml	Edgar Link	completed
bhc-20190930.xsd	Edgar Link	pending
bhc-20190930_cal.xml	Edgar Link	unprocessable
bhc-20190930_def.xml	Edgar Link	unprocessable
bhc-20190930_lab.xml	Edgar Link	unprocessable
bhc-20190930_pre.xml	Edgar Link	unprocessable
exhibit311q32019.htm	Edgar Link	pending
exhibit312q32019.htm	Edgar Link	pending
exhibit321q32019.htm	Edgar Link	pending
exhibit322q32019.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2019 Q4 Form 10-Q Financial Statement

#000088559019000037 Filed on November 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2019 Q4 Form 10-Q Financial Statement

#000088559019000037 Filed on November 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc